Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
Igor  Puzanov

Igor Puzanov, M.D., M.S.C.I, F.A.C.P.

Associate Professor of Medicine (Hematology/Oncology)
Associate Director of Phase I Drug Development
Director, Melanoma Clinical Research
Clinical Director, Renal Cancer
VICC Member
Medical Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Henry-Joyce Cancer Clinic
    615-936-8422 or 1-877-936-8422

    Office
    615-343-6653
  • Faxes
    Henry-Joyce Cancer Clinic Fax
    615-343-8668
    Office Fax
    615-343-7602
    Clinic Fax
    615-343-7602
  • Addresses
    Henry-Joyce Cancer Clinic
    1301 Medical Center Drive, Suite 1710
    Nashville, Tennessee 37232-7415
    Website

    Office
    2220 Pierce Avenue
    777 Preston Research Building
    Nashville, TN 37232-6307
Profile

Dr. Puzanov is an Associate Professor of Medicine in the Division of Hematology-Oncology. Dr. Puzanov joined our faculty in July of 2005 after completing a three-year fellowship in Hematology-Oncology at Vanderbilt University Medical Center.
Read more ....

Dr. Puzanov is an Associate Professor of Medicine in the Division of Hematology-Oncology. Dr. Puzanov joined our faculty in July of 2005 after completing a three-year fellowship in Hematology-Oncology at Vanderbilt University Medical Center. He completed his residency in Internal Medicine at University of Texas Southwestern Medical Center at Dallas and was board certified in 2001. Prior to that, he received his M.D. degree from Charles University in Prague. Dr. Puzanov is an Associate Director of the Phase I Program, Director of Melanoma Clinical Research and Clinical Director of Renal Cell Carcinoma. In these roles, he is responsible for the development of new innovative therapies for patients with melanoma and RCC as well as co-leadership of a Phase I Program with emphasis on the genomic data integration and immunotherapy concepts. He leads collaborations with the cardiology department to study cardiotoxicity of anti-VEGF therapies for cancer and with Radiation Oncology department on the synergistic effects between radiation and immunotherapies.

Education
  • Charles University, Prague, Czechoslovakia, M.D., 1991
  • Internship, Internal Medicine and Surgery, Faculty Hospital Royal Vineyards
  • Residency/Internship, Internal Medicine, UT Southwestern Medical Center
  • Fellowship in Medical Oncology and Hematology, Vanderbilt University
  • Master of Science in Clinical Investigation, Vanderbilt University
Clinical Interest

Development of novel therapies for patients with solid tumors including melanoma and renal cell carcinoma

Publications